Cencora Inc. stock eases after insider sale while earnings grow
Published on 09/19/2026 at 10:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cencora Inc. stock (ISIN US15135B1017) most recently closed at USD 309.39 on the New York Stock Exchange as of September 17, 2026, down 2.86 percent from the prior close, reflecting renewed volatility around insider trading activity and recent earnings figures.
Insider share sale adds short term pressure
According to StockTitan on September 17, 2026, Cencora director Lon R. Greenberg reported selling 1,280 shares of common stock on September 16, 2026 at USD 321.30 per share, for total proceeds of about USD 411,264.
Per options data outlined in a recent market overview, Cencora Inc. shares closed at USD 309.39 on the New York Stock Exchange on September 17, 2026, down USD 9.11 or 2.86 percent from the prior close, before rebounding in after hours trading to around USD 327.50, a move of 5.85 percent from the regular session close.
Earnings growth supports valuation
As summarized in a recent earnings commentary, Cencora Inc. most recently reported earnings per share rising from USD 4.00 to USD 4.48 year over year in its latest fiscal period, an increase of 12 percent that outpaced revenue growth of 5.1 percent over the same period.
The same overview noted that Cencora maintained a net margin below 1 percent in this latest period, highlighting the structurally low margin profile that is typical for large scale pharmaceutical distribution businesses even when top line and earnings expand.
Stock valuation and market metrics
A current stock portal overview shows Cencora shares trading around USD 308.62 as of late trading on September 18, 2026 on the New York Stock Exchange, with the stock having declined about 8.7 percent year to date from USD 338.07 on January 1, 2026.
The same data indicate a 52 week trading range between USD 244.82 and USD 377.54 for Cencora Inc. stock, placing the latest price level roughly in the middle of that band and signaling that investors have recently stepped back from the upper end of the range following the insider sale.
According to a market capitalization overview as of September 17, 2026, Cencora carries a market cap of about USD 59.04 billion based on a share price slightly above USD 309, ranking the company among the more valuable health care distributors globally.
Closing price and investor takeaway
Cencora Inc. stock closed at USD 309.39 on the New York Stock Exchange on September 17, 2026, with the after hours indication of around USD 327.50 underscoring that, despite short term pressure from insider selling, the shares continue to trade at a robust level supported by recent earnings growth and a solid market capitalization.
Cencora Inc. stock key data
- Company: Cencora Inc.
- ISIN: US15135B1017
- Ticker: COR
- Trading venue: New York Stock Exchange
- Price (as of September 17, 2026): 309.39 USD
- Market capitalization: 59.04 billion USD (as of September 17, 2026)
- Sector / Industry: Health care distribution
- Index membership: S&P 500
